Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
Emi E. Nakayama, Tatsuo Shioda
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1015-1015
Open Access | Times Cited: 21
SARS‐CoV‐2 IgG antibodies in COVID‐19 convalescent plasma and conventional plasma units
Andrew Sulaiman, Isabella Sengsouk, Jodie L. White, et al.
Transfusion (2025)
Closed Access
Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 years after COVID-19 infection
Mariam Movsisyan, Nune Truzyan, И. Э. Каспарова, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Development of hybrid immunity during a period of high incidence of Omicron infections
Anja Frei, Marco Kaufmann, Rebecca Amati, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 6, pp. 1696-1707
Open Access | Times Cited: 11
Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination
Alexander Hönning, Sara Tomczyk, Júlia Hermes, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
SARS-CoV-2 Neutralizing Antibodies in Three African Countries Following Multiple Distinct Immune Challenges
Diary Juliannie Ny Mioramalala, Rila Ratovoson, Paul Alain Tagnouokam‐Ngoupo, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 363-363
Open Access | Times Cited: 2
Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination
Letizia Scola, Donatella Ferraro, Giuseppa Luisa Sanfilippo, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 413-413
Open Access | Times Cited: 7
Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges Among Vaccinated Health Care Workers at a Boston Hospital
Maura C Dodge, Lei Ye, Elizabeth R. Duffy, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 7
Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies
Mackenzie Zendt, Fausto Andres Bustos Carrillo, Sophie Kelly, et al.
Science Advances (2023) Vol. 9, Iss. 41
Open Access | Times Cited: 7
SARS-CoV-2 Antibody Dynamics in Healthcare Workers after mRNA Vaccination
Kevin D. Dieckhaus, Min Jung Kim, Jianbing Shen, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 358-358
Open Access | Times Cited: 6
Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study
Rebecca Amati, Giovanni Piumatti, Giovanni Franscella, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3703-3703
Open Access | Times Cited: 5
Anti-S Antibodies Against SARS-CoV-2 Infection Among Four Types of Vaccines in Malaysia
Noor Aliza Lodz, Nurdiyana Farhana Mat Tamizi, Mohd Hatta Abd Mutalip, et al.
Asia Pacific Journal of Public Health (2024) Vol. 36, Iss. 1, pp. 96-103
Open Access | Times Cited: 1
SARS-CoV-2 Neutralizing Antibodies in Three African Countries Following Multiple Distinct Immune Challenges
Diary Juliannie Ny Mioramalala, Rila Ratovoson, Paul Alain Tagnouokam‐Ngoupo, et al.
(2024)
Open Access | Times Cited: 1
Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents—Georgia, October 2020–July 2022
Zeshan Chisty, Deana D. Li, Melia Haile, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301367-e0301367
Open Access | Times Cited: 1
Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature
Andrew Holtz, Johan Van Weyenbergh, Samuel L. Hong, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
F Panza, Fabio Fiorino, G Pastore, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2607-2607
Open Access | Times Cited: 3
Development of hybrid immunity during a period of high incidence of infections with Omicron subvariants: A prospective population based multi-region cohort study
Anja Frei, Marco Kaufmann, Rebecca Amati, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates
Sarah N. Tedjakusuma, Colin A. Lester, Elena D. Neuhaus, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 132-132
Open Access
Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature
Andrew Holtz, Johan Van Weyenbergh, Samuel L. Hong, et al.
Research Square (Research Square) (2024)
Open Access
Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2
Nagashige Shimada, Satoshi Sugawa, Satoshi Murakami, et al.
Vaccine X (2024) Vol. 19, pp. 100518-100518
Open Access
Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys
Christopher L. Coe, Francesca A. Nimityongskul, Gabriele R. Lubach, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 929-929
Open Access
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study
S Mestiri, Maysaloun Merhi, Varghese Inchakalody, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study
Jorge Hernández‐Bello, José Julio Sierra-García-de-Quevedo, José Javier Morales‐Núñez, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1127-1127
Open Access | Times Cited: 1
Case Report: Kinetics and durability of humoral and cellular response of SARS-CoV-2 messenger RNA vaccine in a lung and kidney transplant recipient
James P. Long, Mithil Soni, Pawel Muranski, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1
Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity
Nahad Sedaghat, Masoud Etemadifar, Noushin Lotfi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Page 1 - Next Page

Scroll to top